Comparison of whole blood vs purified blood granulocytes for the detection and quantitation of JAK2V617F

被引:22
作者
Hermouet, S. [1 ]
Dobo, I.
Lippert, E.
Boursier, M-C
Ergand, L.
Perrault-Hu, F.
Pineau, D.
机构
[1] CHU Nantes, Hematol Lab, F-44035 Nantes 01, France
[2] CHU Angers, Hematol Lab, Angers, France
[3] Ctr Hosp Univ Bordeaux, Hematol Lab, Bordeaux, France
关键词
D O I
10.1038/sj.leu.2404588
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:1128 / 1130
页数:3
相关论文
共 8 条
  • [1] Latent myeloproliferative disorder revealed by the JAK2-V617F mutation and endogenous megakaryocytic colonies in patients with splanchnic vein thrombosis
    Boissinot, Marjorie
    Lippert, Eric
    Girodon, Francois
    Dobo, Irene
    Fouassier, Marc
    Masliah, Claude
    Praloran, Vincent
    Hermouet, Sylvie
    [J]. BLOOD, 2006, 108 (09) : 3223 - 3224
  • [2] Standardization and comparison of endogenous erythroid colony assays performed with bone marrow or blood progenitors for the diagnosis of polycythemia vera
    Dobo, L
    Donnard, M
    Girodon, F
    Mossuz, P
    Boiret, N
    Boukhari, R
    Allègraud, A
    Bascans, E
    Campos, L
    Pineau, D
    Turlure, P
    Praloran, V
    Hermouet, S
    [J]. HEMATOLOGY JOURNAL, 2004, 5 (02) : 161 - 167
  • [3] GIRODON F, IN PRESS HAEMATOLOGI
  • [4] Detection of JAK2 V617F as a first intention diagnostic test for erythrocytosis
    James, C
    Delhommeau, F
    Marzac, C
    Teyssandier, I
    Le Couédic, JP
    Giraudier, S
    Roy, L
    Saulnier, P
    Lacroix, L
    Maury, S
    Tulliez, M
    Vainchenker, W
    Ugo, V
    Casadevall, N
    [J]. LEUKEMIA, 2006, 20 (02) : 350 - 353
  • [5] A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera
    James, C
    Ugo, V
    Le Couédic, JP
    Staerk, J
    Delhommeau, F
    Lacout, C
    Garçon, L
    Raslova, H
    Berger, R
    Bennaceur-Griscelli, A
    Villeval, JL
    Constantinescu, SN
    Casadevall, N
    Vainchenker, W
    [J]. NATURE, 2005, 434 (7037) : 1144 - 1148
  • [6] Acquisition of the V617F mutation of JAK2 is a late genetic event in a subset of patients with myeloproliferative disorders
    Kralovics, Robert
    Teo, Soon-Siong
    Li, Sai
    Theocharides, Alexandre
    Buser, Andreas S.
    Tichelli, Andre
    Skoda, Radek G.
    [J]. BLOOD, 2006, 108 (04) : 1377 - 1380
  • [7] The JAK2-V617F mutation is frequently present at diagnosis in patients with essential thrombocythemia and polycythemia vera
    Lippert, Eric
    Boissinot, Marjorie
    Kralovics, Robert
    Girodon, Francois
    Dobo, Irene
    Praloran, Vincent
    Boiret-Dupre, Nathalie
    Skoda, Radek C.
    Hermouet, Sylvie
    [J]. BLOOD, 2006, 108 (06) : 1865 - 1867
  • [8] Relation between JAK2 (V617F) mutation status, granulocyte activation, and constitutive mobilization of CD34+ cells into peripheral blood in myeloproliferative disorders
    Passamonti, F
    Rumi, E
    Pietra, D
    Della Porta, MG
    Boveri, E
    Pascutto, C
    Vanelli, L
    Arcaini, L
    Burcheri, S
    Malcovati, L
    Lazzarino, M
    Cazzola, M
    [J]. BLOOD, 2006, 107 (09) : 3676 - 3682